A 58-year-old man with newly diagnosed type 2 diabetes has HbA1c 8.2 percent despite three months of lifestyle modification. He has no established cardiovascular disease, eGFR is 80 mL per minute per 1.73 m2, and BMI is 31 kg per m2. According to Diabetes Canada pharmacologic recommendations, what is the preferred initial pharmacologic therapy?